VJHemOnc is committed to improving our service to you

IMW 2019 | Transplantation in modern myeloma therapeutics

VJHemOnc is committed to improving our service to you

Andrew Spencer, David Siegel, Mohamad Mohty and Philip McCarthy

The need for transplantation in myeloma is frequently a topic of interest when discussing the most effective treatment options, due to the increased availability of novel therapeutics. Here, Mohamad Mohty, MD, PhD, University Pierre & Marie Curie, Paris, France is joined with Philip McCarthy, MD, of University at Buffalo, Buffalo, NY, Andrew Spencer, MBBS, FRACP FRCPA, DM, of Alfred Hospital, Monash University, Melbourne, Australia, and David Siegel, MD, PhD, of the John Theurer Cancer Center, Hackensack, NJ, to debate whether transplantation is still relevant in today’s clinical practice.

Share this video  
Similar topics

Sign-up for our Newsletter!

Keep up to date with all the latest news with our monthly newsletter